- Title
- ALSUntangled No. 8: Low dose naltrexone for ALS
- Creators
- Steven NovellaRichard BedlackOrla HardimanPaul WicksJames HeywoodL. P. RowlandMerit CudkowiczEric PioroLisa KinsleyKathy MitchellJonathan GlassSith SathornsumeteeHubert KwiecinskiJon BakerNazem AtassiDallas ForshewJohn RavitsRobin ConwitCarlayne JacksonAlex ShermanKate DaltonKatherine TindallGinna GonzalezJanice RobertsonLarry PhillipsMichael BenatarEric SorensonChristen ShoesmithSteven NashNicholas MarigakisDan MooreJames CaressKevin BoylanCarmel ArmonMegan GrossoBonnie GereckeJim WymerBjorn OskarssonRobert BowserVivian DroryJeremy ShefnerTerry Heiman-PattersonNoah LechtzinMelanie LeitnerRobert MillerHiroshi MitsumotoTodd LevineJames RussellKhema SharmaDavid SapersteinLeo McCluskyDaniel MacGowanJonathan LichtAshok VermaMichael StrongCatherine Lomen-HoerthRup TandanMichael RivnerLisa KrivickasSteve KolbMeraida PolakStacy RudnickiPamela KittrellMuddasir QuereshiGeorge SachsGary PatteeTahseen MozaffarMichael WeissJohn KisselJonathan GoldsteinJeffrey RothsteinDan PastulaALSUntangled Grp
- Publication Details
- Amyotrophic lateral sclerosis, Vol.12(1), pp.76-78
- Publisher
- Taylor & Francis
- Number of pages
- 3
- Academic Unit
- Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuromuscular Disorders Div; School of Architecture; School of Architecture
- Language
- English
- Resource Type
- Journal article
- PMID
- 21174518
- Record Identifier
- 991031725580502976
Journal article
ALSUntangled No. 8: Low dose naltrexone for ALS
Amyotrophic lateral sclerosis, Vol.12(1), pp.76-78
2011-01-01
PMID: 21174518
Metrics
7 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.43 Anesthesiology
- 1.43.320 Morphine
- Web Of Science research areas
- Clinical Neurology
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites